Stevens Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-748
Closed -$205K – 313
2025
Q3
$205K Buy
+748
New +$204K 0.03% 244
2025
Q1
– Sell
-1,012
Closed -$231K – 376
2024
Q4
$231K Sell
1,012
-480
-32% -$116K 0.09% 276
2024
Q3
$364K Buy
1,492
+418
+39% +$93.4K 0.05% 142
2024
Q2
$206K Buy
+1,074
New +$218K 0.07% 206
2024
Q1
– Sell
-6,513
Closed -$1.12M – 348
2023
Q4
$1.12M Buy
+6,513
New +$1M 0.28% 79
2023
Q2
– Sell
-1,721
Closed -$377K – 298
2023
Q1
$377K Buy
+1,721
New +$373K 0.09% 138
2022
Q2
– Sell
-2,361
Closed -$573K – 242
2022
Q1
$573K Sell
2,361
-607
-20% -$147K 0.13% 155
2021
Q4
$773K Buy
+2,968
New +$770K 0.18% 131
2019
Q2
– Sell
-104,627
Closed -$10.9M – 815
2019
Q1
$10.9M Buy
+104,627
New +$10.8M 0.46% 53
2018
Q4
– Sell
-72,237
Closed -$8.33M – 879
2018
Q3
$8.33M Buy
+72,237
New +$7.91M 0.3% 100
2016
Q2
– Sell
-25,648
Closed -$1.48M – 1093
2016
Q1
$1.48M Sell
25,648
-54,543
-68% -$3.09M 0.06% 343
2015
Q4
$4.3M Buy
+80,191
New +$4.52M 0.17% 174
2015
Q3
– Sell
-3,990
Closed -$225K – 1181
2015
Q2
$225K Buy
+3,990
New +$252K 0.01% 838
2014
Q1
– Sell
-110,364
Closed -$5.2M – 1279
2013
Q4
$5.2M Buy
+110,364
New +$5.59M 0.15% 165
2013
Q3
– Sell
-38,541
Closed -$1.74M – 1184
2013
Q2
$1.74M Buy
+38,541
New +$1.83M 0.06% 343

Other funds holding RMD

Stevens Capital Management's RMD Position: Q4 2025 in Review

Stevens Capital Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 748 shares — an estimated $205K sold.

Stevens Capital Management first reported a position in RMD in Q2 2013 and held it in 15 quarters. The position peaked at $10.9M in Q1 2019. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Stevens Capital Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Stevens Capital Management sold 748 ResMed shares in Q4 2025, an estimated $205K.
  • Stevens Capital Management first reported a position in ResMed in Q2 2013 and held it in 15 quarters.
  • Stevens Capital Management's ResMed position peaked at $10.9M in Q1 2019.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Stevens Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.